Related Experiment Video
Updated: Oct 3, 2025
06:59
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
Published on: June 13, 2016
10.5K
Integrated microfluidic system for isolating exosome and analyzing protein marker PD-L1.
Yunxing Lu1, Ling Ye2, Xiaoyu Jian3
1State Key Laboratory of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, China; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, China.
Biosensors & Bioelectronics
|February 18, 2022
Summary
This study introduces an integrated microfluidic system for rapid exosome analysis. The system accurately quantifies PD-L1 protein on exosomes, aiding in personalized cancer immunotherapy strategies.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Research
Background:
- Exosomes mediate intercellular communication and are valuable biomarkers for disease detection and therapeutics.
- PD-L1 (Programmed Death-Ligand 1) is a key protein expressed by tumors to evade immune responses.
- Current methods for exosome analysis are often time-consuming and complex.
Purpose of the Study:
- To develop an integrated microfluidic exosome isolation and detection (EXID) system.
- To analyze the abundance of exosomal PD-L1 protein for potential therapeutic applications.
- To reduce the time required for exosome biomarker analysis.
Main Methods:
- An integrated microfluidic chip was designed for simultaneous exosome isolation, biomarker labeling, and quantification.
- The EXID system was used to profile 7 cell lines, including cancer cell lines and control samples.
- Clinical samples from cancer patients and healthy controls were analyzed for exosomal PD-L1 levels.
Main Results:
- The EXID system achieved a total analysis time of under 2 hours.
- Significant differences in fluorescence intensity (PD-L1 abundance) were observed across cell lines, with a limit of detection as low as 10.76 per microliter.
- Variations in PD-L1 levels were detected in clinical samples, correlating with immune response sensitivity.
Conclusions:
- The EXID system offers a rapid and efficient method for analyzing exosomal PD-L1.
- Exosomal PD-L1 abundance varies significantly among cancer types, supporting the need for personalized treatment approaches.
- This technology can guide the design of effective immunotherapy strategies by assessing tumor immune response sensitivity.
